Concord Drugs Ltd Peer Comparison
CONCORD · Healthcare · Current price ₹71.52
Peers tracked
11
Concord Drugs Ltd P/E
238.4x
Sector
Healthcare
Concord Drugs Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,961.9 | 39.1x | 4,67,127 |
| Divis Laboratories Ltd | ₹7,330 | 69.1x | 1,93,314 |
| Torrent Pharmaceuticals Ltd | ₹5,040.7 | 72.9x | 1,84,258 |
| Zydus Lifesciences Ltd | ₹1,143.1 | 22.0x | 1,14,942 |
| Cipla Ltd | ₹1,432.5 | 30.3x | 1,14,520 |
| Lupin Ltd | ₹2,514.8 | 20.6x | 1,12,155 |
| Mankind Pharma Ltd | ₹2,579.5 | 53.7x | 1,04,641 |
| Dr Reddys Laboratories Ltd | ₹1,206 | 26.8x | 1,01,496 |
| Aurobindo Pharma Ltd | ₹1,579.7 | 25.9x | 88,085 |
| Laurus Labs Ltd | ₹1,593.2 | 92.8x | 82,879 |
| Concord Drugs Ltd | — | 85.3x | 94 |
Concord Drugs Ltd versus its peers
Concord Drugs Ltd operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 238.4x may be cheap in one industry and expensive in another.
More on Concord Drugs Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.